Lund University Hospital Study Validates Improved Long-Term Clinical Outcomes Using Stereotaxis Technology
Lead author Dr.
In the study, 112 consecutive AF patients were ablated utilizing the Niobe system versus 102 patients with manual navigation. The Niobe patient group experienced significantly shorter fluoroscopy time (11.1±6.3 vs. 16.9±10.8 min, P <0.05) and fewer major complications (1 significant PV stenosis vs. 3 tamponades) than the manual patient group. Furthermore, after 33±8/42±9 months of follow-up, significantly better clinical efficacy (P <0.05) was found in the Niobe group (AF free or markedly improved: 64% after 1st and 81% after 2nd ablation, respectively) than in the manual group (52% after 1st and 67% after 2nd ablation, respectively).
“On a personal note, the convenience and ease of use associated with the Niobe system alleviates much of the physical burden related to these complex procedures, enabling me to continue practicing electrophysiology longer than expected,” said Dr. Yuan, who performed his first procedure using the Niobe system in late 2011 and has since completed more than 300 cases. Collectively, physicians at
The core components of Stereotaxis’ systems have received regulatory clearance in
This press release includes statements that may constitute "forward-looking" statements, usually containing the words "believe”, "estimate”, "project”, "expect" or similar expressions. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors that would cause or contribute to such differences include, but are not limited to, the Company's ability to raise additional capital on a timely basis and on terms that are acceptable, its continued listing on the
STXS Company Contact:
Martin StammerChief Financial Officer 314-678-6155 STXS Investor Contact: Todd Kehrli/ Jim Byers MKR Group, Inc.323-468-2300 email@example.com